Cardiol Therapeutics Inc. Quarterly Liabilities in CAD from Q4 2020 to Q4 2024

Taxonomy & unit: ifrs-full: CAD
Summary: Cardiol Therapeutics Inc. quarterly Liabilities history and growth rate from Q4 2020 to Q4 2024.
Cardiol Therapeutics Inc. Liabilities for the quarter ending December 31, 2024 was CA$7.14M, a 15.6% decline year-over-year.

Liabilities, Quarterly (CAD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	7.14M	-1.32M	-15.6%	Dec 31, 2024	40-F	2025-03-31
Q4 2023	8.45M	-1.37M	-14%	Dec 31, 2023	40-F	2025-03-31
Q4 2022	9.83M	-1.81M	-15.6%	Dec 31, 2022	20-F	2024-04-01
Q4 2021	11.6M	+9.02M	+344%	Dec 31, 2021	20-F	2023-03-29
Q4 2020	2.62M			Dec 31, 2020	40-F/A	2022-04-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.